NYSE:BHC Bausch Health Cos (BHC) Stock Price, News & Analysis $5.70 +0.05 (+0.80%) Closing price 09/25/2026 03:59 PM EasternExtended Trading$5.75 +0.06 (+0.98%) As of 09/25/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Bausch Health Cos Stock (NYSE:BHC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Bausch Health Cos alerts:Sign Up Key Stats Today's Range$5.63▼$5.8350-Day Range$4.43▼$7.0152-Week Range$4.33▼$8.00Volume1.25 million shsAverage Volume2.29 million shsMarket Capitalization$2.13 billionP/E RatioN/ADividend YieldN/APrice Target$8.00Consensus RatingHold Company Overview Bausch Health Companies Inc. is a multinational specialty pharmaceutical company headquartered in Laval, Quebec. The company develops, manufactures and markets prescription medicines, over-the-counter products and medical devices, with a focus on gastroenterology, neurology, dermatology and other specialty therapeutic areas. Its portfolio includes gastrointestinal treatments such as Xifaxan, Trulance and Relistor, as well as products for conditions affecting the central nervous system and skin. Bausch Health also markets the Solta Medical portfolio of aesthetic medical devices. Its former eye-health business, Bausch + Lomb, was separated from Bausch Health as an independent publicly traded company in 2022. The company traces its history to Valeant Pharmaceuticals International and adopted the Bausch Health name in 2018. Bausch Health serves patients and healthcare providers through operations and commercial activities in North America and international markets. Thomas J. Appio serves as the company's chief executive officer.AI Generated. May Contain Errors. Read More Bausch Health Cos Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks59th Percentile Overall ScoreBHC MarketRank™: Bausch Health Cos scored higher than 59% of companies evaluated by MarketBeat, and ranked 379th out of 903 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.7 / 5Analyst RatingHold Consensus RatingBausch Health Cos has received a consensus rating of Hold. The company's average rating score is 2.14, and is based on 1 strong buy rating, no buy ratings, 5 hold ratings, and 1 sell rating.Upside PotentialBausch Health Cos has a consensus price target of $8.00, representing about 40.5% upside from its current price of $5.70.Amount of Analyst CoverageBausch Health Cos has only been the subject of 3 research reports in the past 90 days.Read more about Bausch Health Cos' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings Growth-7.59% Earnings GrowthEarnings for Bausch Health Cos are expected to decrease by -7.59% in the coming year, from $4.35 to $4.02 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Bausch Health Cos is -1.92, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Bausch Health Cos is -1.92, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioBausch Health Cos has a P/B Ratio of 5.58. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Bausch Health Cos' valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.91% of the float of Bausch Health Cos has been sold short.Short Interest Ratio / Days to CoverBausch Health Cos has a short interest ratio ("days to cover") of 3.06, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Bausch Health Cos has recently increased by 4.96%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldBausch Health Cos does not currently pay a dividend.Dividend GrowthBausch Health Cos does not have a long track record of dividend growth. News and Social Media3.1 / 5News Sentiment0.91 News SentimentBausch Health Cos has a news sentiment score of 0.91. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.74 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 7 news articles for Bausch Health Cos this week, compared to 4 articles on an average week.Search InterestOnly 4 people have searched for BHC on MarketBeat in the last 30 days. This is a decrease of -69% compared to the previous 30 days. Company Ownership2.1 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Bausch Health Cos insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $258,894.00 in company stock.Percentage Held by Insiders20.67% of the stock of Bausch Health Cos is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions78.65% of the stock of Bausch Health Cos is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Bausch Health Cos' insider trading history. Receive BHC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bausch Health Cos and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BHC Stock News HeadlinesZacks Research Analysts Increase Earnings Estimates for BHCSeptember 25 at 1:13 AM | americanbankingnews.comBausch Health Cos Inc. (NYSE:BHC) Given Consensus Recommendation of "Reduce" by AnalystsSeptember 23, 2026 | americanbankingnews.comYou Won’t Get a Warning Before This Correction HitsGold just broke another record - a classic flight-to-safety signal that the smartest money on Wall Street is already acting on. With the NASDAQ pricing in optimism over fundamentals and global tensions continuing to rise, a market correction could arrive without warning. Our research team just released a free crash-protection guide identifying which stocks and sectors can hold strong even when the broader market crumbles.September 27 at 1:00 AM | StockEarnings (Ad)Bausch Health and YUN Announce Expansion to Mexico and Across Additional EMEA MarketsSeptember 8, 2026 | prnewswire.comBausch Health Companies Inc. (BHC)August 28, 2026 | finance.yahoo.comBausch Health's Ortho Dermatologics Announces the 2026 Aspire Higher Scholarship WinnersAugust 27, 2026 | prnewswire.comBausch + Lomb: The Market Is Pricing The Balance Sheet, Not The Eye-Care EngineAugust 20, 2026 | seekingalpha.comBausch Health Announces 2026 Gastrointestinal Health Scholars Program WinnersAugust 17, 2026 | prnewswire.comSee More Headlines BHC Stock Analysis - Frequently Asked Questions How have BHC shares performed this year? Bausch Health Cos' stock was trading at $6.95 at the beginning of the year. Since then, BHC stock has decreased by 18.1% and is now trading at $5.6950. How were Bausch Health Cos' earnings last quarter? Bausch Health Cos Inc. (NYSE:BHC) released its quarterly earnings results on Wednesday, July, 29th. The company reported $1.26 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.96 by $0.30. The firm had revenue of $2.83 billion for the quarter, compared to analyst estimates of $2.59 billion. Bausch Health Cos had a negative net margin of 10.12% and a negative trailing twelve-month return on equity of 561.95%. Read the conference call transcript. Who are Bausch Health Cos' major shareholders? Top institutional shareholders of Bausch Health Cos include Paulson & CO. Inc. (19.58%), MFN Partners Management LP (1.60%), Private Management Group Inc. (0.45%) and Man Group plc (0.39%). Insiders that own company stock include John Paulson, Seana Carson, Aimee J Lenar and Frank D Lee. View institutional ownership trends. How do I buy shares of Bausch Health Cos? Shares of BHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Bausch Health Cos own? Based on aggregate information from My MarketBeat watchlists, some other companies that Bausch Health Cos investors own include Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), Alibaba Group (BABA), Tesla (TSLA), Bristol Myers Squibb (BMY) and Gilead Sciences (GILD). Company Calendar Last Earnings7/29/2026Today9/27/2026Next Earnings (Estimated)10/28/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 BHC's financial health is in the Green zone, according to TradeSmith. BHC has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNYSE:BHC CIK885590 Webwww.bauschhealth.com Phone(514) 744-6792Fax514-744-6272Employees20,300Year Founded1959Price Target and Rating Average Price Target for Bausch Health Cos$8.00 High Price Target$9.00 Low Price Target$7.00 Potential Upside/Downside+40.5%Consensus RatingHold Rating Score (0-4)2.14 Research Coverage7 Analysts Profitability EPS (Trailing Twelve Months)($2.96) Trailing P/E RatioN/A Forward P/E Ratio1.31 P/E GrowthN/ANet Income$157 million Net Margins-10.12% Pretax Margin-6.74% Return on Equity-561.95% Return on Assets6.31% Debt Debt-to-Equity Ratio54.68 Current Ratio1.44 Quick Ratio1.08 Sales & Book Value Annual Sales$10.85 billion Price / Sales0.20 Cash Flow$7.30 per share Price / Cash Flow0.78 Book Value$1.02 per share Price / Book5.58Miscellaneous Outstanding Shares374,140,000Free Float296,805,000Market Cap$2.13 billion OptionableOptionable Beta0.37 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NYSE:BHC) was last updated on 9/27/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bausch Health Cos Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bausch Health Cos With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
